Abstract PURPOSE OF REVIEW Osteoarthritis (OA) is a painful disease for which drug development has proven difficult. One major reason for this is the heterogeneity of the disease and the current lack of operationalized means to distinguish various disease endotypes (molecular subtypes). Biomarkers measured in blood or urine, reflecting joint tissue turnover, have been developed […]
Blood and urine biomarkers in osteoarthritis – an update on cartilage associated type II collagen and aggrecan markers.
January 1, 2022
Curr Opin Rheumatol